In this third stage, Parkinson's disease significantly advances, and it is often considered mid-stage in the entire progression of the disorder. Loss of balance is finally experienced and the pull test is performed to check. If you don't regain your balance and the healthcare provider has to...
doi:10.1016/j.gaitpost.2019.07.470M. GiardiniI. ArcolinM. GodiA. NardoneS. CornaElsevier BVGait & Posture
Parkinson's disease dementia (PDD) Frontotemporal disorders (FTD) This is a group of neurodegenerative brain disorders that primarily affect the frontal and temporal lobes of your brain. Your frontal lobe partly controls your personality, decision-making, movement, and ability to smell and speak. Ch...
Parkinson's disease dementia (PDD) Frontotemporal disorders (FTD) This is a group of neurodegenerative brain disorders that primarily affect the frontal and temporal lobes of your brain. Your frontal lobe partly controls your personality, decision-making, movement, and ability to smell and speak. Ch...
Progression of brain atrophy in the early stages of Parkinson's disease: a longitudinal tensor-based morphometry study in de novo patients without cognitive impairment. Hum Brain Mapp 2014; 35: 3932-3944.Tessa C, Lucetti C, Giannelli M, Diciotti S, Poletti M, et al. (2014) Progression ...
This study explores prodromal Parkinson's Disease (PD) by leveraging data from the Parkinson's Progression Markers Initiative (PPMI). The main goal was to discriminate between prodromals that phenoconverted to PD in 7 years to those that did not. Through feature selection, the system identified ...
Objective To investigate which factors are associated with the quality of life decline in Parkinson's disease patients from mild to moderate stages. Methods The Unified Parkinson's Disease Rating Scale and Parkinson's Disease Questionnaire-39 were used to evaluate clinical/functional data and the ...
Stimulation of a specific site in the dorsolateral subthalamic nucleus (STN) was recently associated with slower motor progression in Parkinson's Disease (PD), based on the deep brain stimulation (DBS) in early-stage PD pilot clinicaltrial. Here, subject-level visualizations are presented of this...
Objectives A model of Parkinson's Disease (PD) progression over twenty-five years was developed to assess long term economic consequences of slowing progression in a German setting. Methods Expected time to progression between Hoehn and Yahr (H & Y) stages for the base case was based on a ...
Objectives To estimate the economic benefits of slowing Parkinson's Disease (PD) progression to Medicare, private insurers, and patients. Recent research demonstrated large societal economic gains from slowing PD progression through Hoehn and Yahr (H & Y) stages. Herein, we consider economic benefits...